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ABSTRACT
INTRODUCTION: In an unprecedented era of soaring healthcare costs, payers and providers
alike have started to place increased importance on measuring the quality of surgical procedures
as surrogate markers for operative success. Length of hospital stay (LOS) and discharge
disposition during index admission are two metrics increasingly used. For the treatment of
unruptured cerebral aneurysms, the determinants of extended length of stay and poor discharge
disposition remain relatively unknown.
OBJECTIVES: 1) To investigate the influence that patient demographics, such as gender and
race, have on post-procedural discharge disposition after treatment of unruptured aneurysms, and
2) To identify the nationwide impact of patient- and hospital-level factors associated with
extended LOS following intervention for unruptured cerebral aneurysms.
METHODS: In three separate studies, patients in the National Inpatient Sample database years
2010 to 2014 were queried. Adults (≥ 18 years) presenting with an unruptured cerebral aneurysm
were selected using the International Classification of Diseases, Ninth Revision, Clinical
Modification coding system. In the first study, patients were categorized by race (White and
Black). In the second study, patients were categorized by gender (Male and Female). In the third
study, patients were categorized by whether they encountered an extended LOS. For the latter,
national estimates were also calculated by using weighting provided by the healthcare cost and
utilization project (HCUP). Extended LOS was defined as greater than 75th percentile for the
entire cohort (>5 days). Multivariate logistic regression analysis was used to determine the odds
ratio for risk-adjusted discharge disposition and extended LOS. The primary outcome was the
degree to which the patient demographics, comorbidities, or postoperative complications
correlated with discharge disposition or extended LOS.
RESULTS: A total of 7,131 patients were identified, 1,062 (14.9%) of whom identified as
Black (White: n=6,069; Black: n=1,062). On average, Black patients experienced one extra day
in the hospital (White: 4.0±5.1 days vs. Black: 5.0±6.6 days, p<0.0001), and a lower proportion
of routine discharges (White: 82.4% vs. Black: 77.4%, p<0.001). On multivariate analysis, Black
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patients were 1.6-fold more likely to have a non-routine discharge than White patients [OR: 1.62,
95% CI (1.34, 1.96), p<0.0001).
A total of 8,467 patients were identified, with 6,391 (75.48%) being Female (Male:
n=1,076; Female: n=6,391). On average, the Male cohort tended to have longer LOS (Male:
4.75±6.78 days vs. Female: 3.99±4.8\\8 days, p<0.0001), and a slightly higher proportion of
routine discharges (Male: 83.2% vs. Female: 81.2%, p=0.01). On multivariate analysis, being
Female was not significantly associated with routine discharge [OR: 0.87, 95% CI (0.74, 1.01),
p=0.07).
A total, weighted 46,880 patients were identified with 9,774 (20.8%) patients having had
extended LOS (Normal LOS: 37,106; Extended LOS: 9,774). The overall complication rates
were greater in the extended LOS cohort (Normal LOS: 7.3% vs. Extended LOS: 43.8%,
P<0.001). On average, the extended LOS cohort incurred a total cost nearly twice as large
(Normal LOS: $26,050 ± 13,430 vs. Extended LOS: $52,195 ± 37,252, P<0.001) and had more
patients encounter non-routine discharges (Normal LOS: 8.5% vs. Extended LOS: 52.5%,
P<0.001) compared to the normal LOS cohort. On weighted multivariate logistic regression
analysis, multiple patient-specific factors were associated with extended LOS. These included
demographics, preadmission comorbidities, choice of procedure, and inpatient complications.
The odds ratio for extended LOS was 5.14 (95% CI, 4.30 – 6.14) for patients with 1
complication and 19.58 (95% CI, 15.75 – 24.34) for patients with > 1 complication.
CONCLUSION: Overall, this study suggests that 1) patient gender is not a significant risk
factor for discharge disposition of patients undergoing treatment intervention for unruptured
cerebral aneurysms and, 2) that racial disparities significantly impact the discharge disposition of
patients undergoing treatment intervention for unruptured cerebral aneurysms. Furthermore, this
study demonstrates that extended LOS after treatment of unruptured aneurysm is influenced by a
number of modifiable patient-specific factors, including both pre- and peri-operative variables.
In a cost-conscious healthcare environment, focusing on aspects of patient demographics and
inpatient care may allow for significant improvement in the care provided while simultaneously
reducing costs.
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INTRODUCTION TO CHAPTERS
In recent years, there has been a national effort to reduce the soaring costs of healthcare
by emphasizing improvements in quality of patient care. In surgery, length of hospital stay
(LOS) and discharge disposition have increasingly become surrogate markers for cost, and are
used to quantify the impact procedures have on the financial burden of hospitals. Therefore, in
the case of intervenable diagnoses with multiple treatment options, assessing LOS and discharge
disposition may highlight ways to improve overall quality of care and to reduce the disparaging
healthcare costs associated with surgery.
Historically, clipping has been the primary choice of treatment for unruptured aneurysms.
Recently, improvements in endovascular coiling have caused a shift in the treatment paradigm,
with an estimated nationwide 15-fold increase in the rate of elective coiling from the early
2000’s to 20141-6. This increase in use has led to multiple institutional studies attempting to
identify potential risk factors for both coiling and clipping outcomes after treatment of
unruptured aneurysm, with fewer studies examining such differences on a nationwide scale3,5,7-9.
For example, in a retrospective analysis of the National Inpatient Sample (NIS) of 31,070
unruptured intracranial aneurysms electively treated from 2011 to 2014, Salahuddin et al.
demonstrated that endovascular coiling continues to increase in use nationally compared to
surgical clipping5. As the number of unruptured aneurysms treated by coiling rises, it is
necessary to investigate nationally the differences in preventable resource utilization for the
various modalities of unruptured cerebral aneurysms.
While previous studies have examined nationwide trends between coiling and clipping,
comparatively few studies have attempted to assess the impact of patient baseline demographics
on the presentation and management for unruptured aneurysm. In one national study using the
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NIS years 1998 to 2007 containing 14,765 unruptured aneurysms treated by either clipping or
coiling, Claus et al. demonstrated that Male patients were 1.26 (95% CI 1.13 to 1.40) times more
likely to undergo coiling than Female patients10. Furthermore, in a retrospective cohort study of
357 patients with unruptured and ruptured aneurysms, Krzyzewski et al. showed that Female
patients had greater risk of harboring multiple aneurysms and left internal carotid artery
aneurysms11. In another nationwide study of 10,545 unruptured aneurysms using the Vizient
Clinical Database, Rinaldo et al. showed that Female sex was positively associated with
admission for unruptured aneurysm, and that Black/Hispanic race was negatively associated with
admission12. The above studies represent an urgent, unmet need to better understand the varied
health outcomes for both race and gender subgroups.
Nationwide, administrative databases that monitor overall healthcare outcomes at the
individual patient level across a variety of hospital settings represent a powerful research tool for
examining the overall impact that pre-, intra-, and postoperative patient characteristics have on
patient care outcomes. In these multiple large, retrospective cohort studies, we used data from
the NIS to investigate differences in gender, race, and extended hospitalization related to the
treatment of unruptured intracranial aneurysms.
Chapter 1 of this thesis investigates the impact of race on post-procedural discharge
disposition after treatment for unruptured aneurysms. Chapter 2 examines the impact of gender
on post-procedural discharge disposition after treatment for unruptured aneurysms. Chapter 3
extends these analyses to comment on national trends using discharge weighting to give national
estimates of aneurysm care, in addition to identifying the patient- and hospital-level factors
associated with extended LOS following intervention for unruptured cerebral aneurysms.
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CHAPTER I
Race is an Independent Predictor for Discharge Disposition After Treatment Intervention
for Unruptured Cerebral Aneurysms
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INTRODUCTION
Racial differences in patient care contribute to disparities in access to necessary
treatments and healthcare resource utilization13,14. An ongoing national effort has ensued to
identify quality metrics of outcomes in order to reduce the disparities in care for ethnic
minorities15. Discharge disposition has gradually become such a proxy, representing the quality
of care hospitals provide for similar treatment interventions16.
According to a review by the Institute of Medicine, while the health of the U.S. has
overall steadily improved, racial minorities continue to experience higher rates of morbidity and
mortality compared to non-minorities15. Black patients, in particular, have been found to
experience poorer outcomes of care in specialties including cardiology, pediatrics, nephrology,
oncology, and pain control17-21. For cerebral aneurysms, previous studies have attempted to
determine the role race has in aneurysm development and risk of subarachnoid hemorrhage
(SAH)22-24. In a retrospective review of 131 patients with SAH, Larrew et al. found that Black
patients had a disproportionately higher incidence of SAH25. The authors showed that
hypertension (HTN), comorbid conditions, and other risk factors such as cigarette smoking were
likely contributors25. While the higher prevalence of these risk factors has been well described in
the African American population, whether race -specifically- is associated with worse discharge
disposition after receiving treatment intervention for unruptured aneurysm, remains relatively
unknown26.
The aim of this study is to investigate the influence race has on post-procedural discharge
disposition after surgical or endovascular treatment for unruptured aneurysms.
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METHODS
Data Source and Patient Population
We utilized the Healthcare Cost and Utilization Project’s National Inpatient Sample
database (HCUP-NIS), a stratified discharge database representing 20% of all inpatient
admissions from non-federal hospitals in the US. The HCUP-NIS is the largest all-payer
healthcare database in the US, containing approximately 7 to 8 million hospital admissions per
year. We performed a retrospective review using the years 2010 to 2014 of the NIS for all
patients undergoing treatment of a unruptured aneurysm.
The International Classification of Diseases, Ninth Revision, Clinical Modification [ICD9-CM] diagnosis and procedural coding system was used to identify patients and their respective
comorbidities and surgical interventions. All patients with a diagnosis of unruptured cerebral
aneurysm (ICD-9-CM 437.3) were identified. Patients with an additional diagnosis of
subarachnoid hemorrhage (ICD-9-CM 430) were excluded. ICD-9-CM procedural codes were
subsequently cross-matched to identify patients in the cohort that underwent endovascular
coiling (ICD-9-CM 39.52, 39.79, 39.72) or surgical clip placement (ICD-9-CM 39.51) for
definitive treatment of their aneurysm. Patients with missing information on gender, race,
mortality, insurance, hospital characteristics or cost data were excluded, as well. After, the cohort
was divided by White race and Black race.

Data Collection
Patient demographic information, comorbidities and treating hospital characteristics were
collected for each patient. Demographic information included age (≥ 18 years), sex, patient
income quartile and primary expected payer (Medicare, Medicaid, private insurer, self-pay, no
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charge, other). Patient income quartile was defined as the median household income for the
patient’s zip code in the specified year. Hospital characteristics included region, size by bed
volume (small, medium, large), and teaching status (rural, urban non-teaching, urban teaching).
Comorbidities included HTN, hyperlipidemia (HLD), primary hypercoagulable state, alcohol
use, atrial fibrillation, chronic obstructive pulmonary disease (COPD), congestive heart failure
(CHF), coronary artery disease (CAD), diabetes, smoking, autosomal dominant polycystic
kidney disease (ADPKD), connective tissue disorder (CTD), peripheral vascular disease (PVD),
or past history of myocardial infarction (Past MI).
Complications for each admission were collected by indexing all additional diagnoses.
The ICD-9-CM diagnosis codes utilized were: postoperative neurologic complication,
postoperative surgical complication, sepsis, bleeding, accidental vessel puncture during the
procedure, deep vein thrombosis (DVT), urinary tract infection, respiratory complication,
abscess or vascular infection, urinary/renal complication, cardiac arrest or insufficiency,
perioperative stroke, myocardial infarction, postoperative infection, dysphagia, and shock. The
primary outcome was discharge disposition between White and Black race. Discharge
disposition was examined by routine (home), non-routine (short-term hospital, skilled nursing
facility, home with healthcare services) and other (died in hospital, discharged to court/law, left
against medical advice, destination unknown) discharge. Patient LOS, inpatient death, and total
charge of admission were assessed as secondary outcomes.

Statistical Analysis
Categorical variables were described using counts and percentages. Continuous variables
were summarized using means and standard deviation if normally distributed, and median with
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interquartile range (IQR) if a non-normal distribution was observed. An Anderson Darling test
for normality was conducted in order to determine the likelihood of a skewed distribution.
Comparison between the groups was conducted by c2 analysis for categorical variables and twosided independent t-test for parametric variables or Kruskal-Wallis testing for non-parametric
variables. A multivariate logistic regression analysis was used to determine the effect of each
risk factor on discharge disposition while adjusting for other potential risk factors. For the
purpose of this analysis, disposition was solely dichotomized by routine or non-routine
discharge. Other disposition categories including leaving against medical advice, discharged to
court/law enforcement, died in hospital or destination unknown were excluded from this portion
of the analysis. A p-value of less than 0.05 was determined to be statistically significant.
Statistical analysis was performed using R Studio, Version 1.1.383 (Rstudio Inc., Boston, MA).
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RESULTS
Patient Demographics, Comorbidities, and Hospital Characteristics
There were 7,131 patients with unruptured aneurysms, of whom 6,069 (85.1 %) identified
as White and 1,062 (14.9%) identified as Black (White: n=6,069 vs. Black: n=1,062) (Figure 1).
The White cohort tended to be older (White: 58 [51 - 67] years vs. Black: 53 [46 - 61], p<0.001)
(Table 1). Both cohorts were comprised of a majority of females (Table 1). While the White
cohort had evenly distributed housing income quartiles, the highest proportion of the Black
cohort was in the 0-25th income quartile (45.8%) (Table 1). The majority of both cohorts paid
with private insurance (White: 46.4% vs. Black: 41.5%, p<0.001) (Table 1). The largest
proportion of procedures was performed in the South (White: 40.9%, Black: 54.0%), in large
hospitals (White: 80.9% vs. Black: 81.5%) (Table 1). Most hospitals were teaching hospitals
located in an urban setting (White: 88.7% vs. Black: 92.7%) (Table 1).
The prevalence of comorbidities differed significantly between the two cohorts. The
Black cohort had a slightly greater proportion of HTN (White: 55.7% vs. Black: 63.7%,
p<0.001), and CHF (White: 1.9% vs. Black: 2.9, p=0.044), and a lower proportion of A Fib
(White: 4.9% vs. Black: 1.8%, p<0.001), COPD (White: 9.7% vs. Black: 4.4%, p<0.001),
coronary artery disease (White: 2.2 vs. n<16, p=0.002), diabetes (White: 3.7% vs. Black: 1.6%,
p=0.001) and slightly greater smoking prevalence (White: 44.3% vs. Black: 38.2%, p<0.001)
(Table 2). There were no significant differences in HLD (p=0.908), primary hypercoagulable
state (p=0.942), alcohol use (p=0.278), ADPKD (p=1.000), CTD (p=1.000), peripheral vascular
disease (p=0.619), and past MI (p=0.832) (Table 2). There was no significant difference
between the interventional choice selected amongst the two cohorts, with the majority of both
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populations undergoing endovascular coiling (White: 57.0% vs. Black: 56.0%, p=0.579) (Table
3).

Perioperative Complications
The Black cohort was overall more likely to have perioperative complications than the
White cohort (White: 14.2% vs. Black 18.3%, p=0.001) (Table 4). Compared to the White
Cohort, Black race was associated with greater postoperative neurologic complications (White:
3.7% vs. Black: 5.4%, p=0.010), bleeding complications (White: 3.8% vs. Black: 5.6%,
p=0.010), respiratory complications (White: 3.0% vs. Black: 4.3%, p=0.029), and perioperative
stroke (White: 3.2% vs. Black: 4.8%, p=0.009) (Table 4). There were no significant differences
in postoperative surgical complications (p=1.000), sepsis (p=0.215) accidental vessel puncture
(p=0.298), DVT (p=0.638), urinary tract infections (p=0.053), abscess or vascular infection
(p=1.000), renal complication (p=0.759), cardiac arrest (p=0.716), MI (p=0.759), postoperative
infection (p=1.000), dysphagia (p=0.267), or shock (p=0.492) (Table 4).

Discharge Disposition, Length of Hospital Stay, Mortality and Total Charge
The proportion of non-routine discharges was significantly greater in the Black cohort
(White: 17.1% vs. Black: 22.1%, p<0.001) (Table 5). On average, LOS was also significantly
greater in the Black cohort by approximately 1 day compared to the White cohort (White: 4.0 ±
5.1 days vs. Black: 5.0 ± 6.6 days, p<0.001) (Table 5). The mortality rate (p=1.000) and median
total charge of admission (p=0.453) between the two cohorts did not significantly differ (Table
5).

On multivariate logistic regression analysis, while controlling for patient demographic
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variables, comorbidities, and complications, Black race was independently associated with nonroutine discharge [Odds-Ratio: 1.62, 95% CI (1.34, 1.96), p<0.0001) (Table 6, Figure 2).
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DISCUSSION
In our nationwide retrospective analysis of 7,131 patients undergoing treatment for
unruptured aneurysm, we demonstrate that race is associated with greater non-routine discharge
and longer hospitalization in patients undergoing surgical or endovascular treatment for
unruptured aneurysm. Furthermore, in a multivariate analysis, Black race was associated with a
1.6-fold greater likelihood of non-routine discharge after treatment intervention.
Previous studies attempted to identify disparities in access and healthcare provision
between Black and White patients. In a retrospective review using the NIS years 2001 to 2009,
Brinjikji et al. demonstrated that, compared to patients undergoing intervention for SAH, patients
offered treatment for unruptured aneurysm were generally from higher socioeconomic groups
and more likely to be White27. Similarly, in another NIS retrospective study of 38,827 patients
with SAH, Sarmiento et al. found that non-White patients were 1.4-fold more likely to
experience treatment delays compared to White patients28. In a retrospective cohort review of
686 patients with intracerebral aneurysms in the American College of Surgeons National
Surgical Quality Improvement program (NSQIP) database by Garcia et al., the authors found that
the proportion of patients treated for SAH was higher among minority subgroups compared to
White patients29. Similarly, in a retrospective study of 424 consecutive patients treated for
unruptured aneurysm at the University of Utah, Guan et al. demonstrated that non-White patients
were significantly more likely to be managed conservatively compared to White patients30.
Using the NIS in a retrospective cohort study of 57,418 unruptured aneurysms, Bekelis et al.
similarly concluded that African Americans were significantly associated with decreased
likelihood of treatment (OR: 0.57)31. Conversely, in another retrospective study examining the
NIS from 1998 to 2007, Lin et al. found that Black patients were in fact just as likely as White
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patients to be treated by coiling for unruptured aneurysm10. Similarly, in a retrospective study of
88 patients with unruptured aneurysms, Gillani et al. demonstrated that race was not associated
with differences in management or offering of procedure32. Consistent with the aforementioned
studies, we found that the large majority of patients undergoing treatment for unruptured
aneurysms in our study cohort were White, with a disproportionate majority of the Black cohort
in the lowest patient income quartile. We found, however, no significant difference in treatment
approach between Black and White patients.
Race may also play an important role in predicting inferior surgical outcomes. In a
national retrospective cohort study of 62,224 patients from 2002-2012, Beydoun et al. showed
that combined clipping and coiling were associated with worse survival compared to solely
surgical clipping for the Black, but not the White, cohort33. Similarly, in a multi-center
retrospective review of 64 patients with SAH, Rodriguez et al. demonstrated that Black race was
an independent predictor of mortality34. Conversely the retrospective study by Garcia et al.,
concluded/determined/demonstrated that postoperative outcomes did not differ between racial
subgroups29. In our study, we demonstrated that Black patients are more likely to experience
overall greater perioperative complications, suggesting racial disparities may significantly affect
surgical outcomes after clipping or endovascular coiling. Additional studies are needed to
examine the disparities in healthcare provision for non-White patients, and to better define
physician screening practices for treating unruptured aneurysms.
While previous studies examined surgical outcomes between different races, few have
investigated differences in discharge disposition. In one retrospective cohort study of 3,498
patients with unruptured aneurysms using the NIS years 1996 to 2000, Barker et al. demonstrated
that race was not significantly associated with discharge other than to home35. Contrarily, in a
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retrospective cohort review of 460 patients undergoing clipping of an unruptured aneurysm using
the NSQIP registry, Dasenbrock et al. demonstrated using multivariable logistic regression
analysis with recursive partitioning analysis that African American race was a significant
independent predictor of non-routine hospital discharge (OR: 4.00)36. Analogously, our study
showed that Black patients experienced a greater likelihood of having a nonroutine hospital
discharge. This discrepancy is, most likely, multifactorial in nature, including genetic,
socioeconomic and surgical risk factors. A future prospective study would allow for more
thorough investigation of the differences between these patient populations including disparities
in socioeconomic determinants of health (e.g. patient incomes, community resources, delayed
access to treatment), and validation of the present findings.
Despite the evidence suggesting discrepancies in care for different racial subgroups in
treatment of unruptured aneurysm, there is a paucity of recent studies aiming to evaluate
differences between race and treatment LOS. In one retrospective case series of all cranial
surgeries among Medicare beneficiaries in 1997, Buczko et al. demonstrated that Black patients
were significantly more likely to have a longer LOS compared to the average patient37. This
study was limited, however, due to intracranial aneurysms comprising only 5.3% of the study’s
patient population37. Our study similarly concluded that LOS was significantly longer for Black
patients compared to White patients. As LOS has become an important proxy for value of care
and cost for hospitals, further well-designed studies are warranted to investigate LOS and the
biopsychosocial differences amongst patients undergoing treatment intervention for unruptured
intracranial aneurysm.
Our study has several inherent limitations common to administrative databases,
including the NIS. First, its retrospective nature and data availability solely by ICD-9-CM
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coding, may harbor coding and reporting biases. Second, the NIS does not contain information
on important clinical details, including symptoms, patient preferences, and procedural details.
Also, the NIS does not have detailed information related to patient postoperative neurologic
outcomes, which could affect patient discharge. Nevertheless, we provide important information
regarding the role race has in the treatment of unruptured aneurysms and its associated
morbidity, complications, and short-term outcomes.
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Table 1: Demographics and Hospital Characteristics
White
Variables
(n= 6,069)
Demographics
Age (Years)
Mean ± SD
58.1 ±11.9
Median [IQR]
58 [51 - 67]
Female (n, %)
4538 (74.8)
Income Quartile (n, %)
0-25th
1306 (21.5)
th
th
26 -50
1662 (27.4)
51st-75th
1569 (25.9)
th
76 -100th
1532 (25.2)
Healthcare Coverage (n, %)
Medicare
2255 (37.2)
Medicaid
553 (9.1)
Private Insurance
2813 (46.4)
Self-Pay
168 (2.8)
No Charge
26 (0.4)
Other
254 (4.2)
Hospital Demographics
Hospital Region (n, %)
Northeast
1226 (20.2)
Midwest
1301 (21.4)
South
2485 (40.9)
West
1057 (17.4)
Hospital Size (n, %)
Small
243 (4.0)
Medium
917 (15.1)
Large
4909 (80.9)
Hospital Type (n, %)
Rural
71 (1.2)
Urban Non-Teaching
614 (10.1)
Urban Teaching
5384 (88.7)

Black
(n=1,062)
53.4±11.7
53 [46 - 61]
863 (81.3)

P-Value

<0.001
<0.001
<0.001
<0.001

486 (45.8)
262 (24.7)
181 (17.0)
133 (12.5)
<0.001
315 (29.7)
201 (18.9)
441 (41.5)
46 (4.3)
n<16
49 (4.6)
<0.001
193 (18.2)
223 (21.0)
573 (54.0)
73 (6.9)
0.834
39 (3.7)
157 (14.8)
866 (81.5)
<0.001
n<16
74 (7.0)
984 (92.7)
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Table 2: Comorbidities
Variables
HTN
HLD
Hypercoagulable State
Alcohol Use
A Fib
COPD
CHF
Coronary Artery Disease
Diabetes
Smoking
ADPKD
CTD
Peripheral Vascular Disease
Past MI

White
(n= 6,069)
3382 (55.7)
415 (6.8)
33 (0.5)
60 (1.0)
295 (4.9)
587 (9.7)
116 (1.9)
135 (2.2)
222 (3.7)
2687 (44.3)
n<16
n<16
114 (1.9)
217 (3.6)

Black
(n=1,062)
677 (63.7)
71 (6.7)
n<16
15 (1.4)
19 (1.8)
47 (4.4)
31 (2.9)
<16
17 (1.6)
406 (38.2)
n<16
n<16
17 (1.6)
36 (3.4)

P-Value
<0.001
0.908
0.942
0.278
<0.001
<0.001
0.044
0.002
0.001
<0.001
1.000
1.000
0.619
0.832

ADPKD = Autosomal Dominant Polycystic Kidney Disease; CTD = Connective Tissue
Disorders
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Table 3: Surgical Approach

Variables
Procedure (n, %)
Endovascular Coiling
Microsurgical Clipping

White
(n= 6,069)

Black
(n=1,062)

P-Value

3459 (57.0)
2610 (43.0)

595 (56.0)
467 (44.0)

0.579
0.579
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Table 4: Postoperative Complications

Variables (n, %)
Any Complication
PNC
PSC
Sepsis
Bleeding*
Accidental vessel puncture during
procedure or carotid injury
DVT
Urinary Tract Infection
Respiratory Complication
Abscess or Vascular Infection
Urinary/Renal Complication
Cardiac Arrest or Insufficiency
Perioperative Stroke
MI
Postoperative Infection
Dysphagia
Shock

White
(n= 6,069)
861 (14.2)
222 (3.7)
80 (1.3)
21 (0.3)
231 (3.8)
36 (0.6)

Black
(n=1,062)
194 (18.3)
57 (5.4)
14 (1.3)
n<16
59 (5.6)
n<16

35 (0.6)
219 (3.6)
182 (3.0)
n<16
n<16
56 (0.9)
192 (3.2)
n<16
n<16
94 (1.5)
n<16

n<16
52 (4.9)
46 (4.3)
n<16
n<16
n<16
51 (4.8)
0
n<16
22 (2.1)
0

P-Value
0.001*
0.010*
1.000
0.215
0.010
0.298
0.638
0.053
0.029*
1.000
0.759
0.716
0.009*
0.759
1.000
0.267
0.492

PNC = Postoperative Neurologic Complications; PSC = Postoperative Surgical Complications
*Bleeding refers to both post-hemorrhagic anemia and hematoma formation
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Table 5: Length of Hospital Stay, Mortality Rates, Discharge Disposition and Total Costs
Variables
Length of Stay (Days)
Mean ± SD
Median [IQR]
Mortality (n, %)
Disposition (n, %)*
Routine
Non-Routine
Other
Total Charge of Admission ($)
Mean ± SD
Median [IQR]

White
(n= 6,069)

Black
(n=1,062)

4.0±5.1
2 [1 - 5]
24 (0.4)

5.0±6.6
3 [2 - 6]
n<16

5001 (82.4)
1039 (17.1)
29 (0.5)

822 (77.4)
235 (22.1)
n<16

108,239 ± 84,514
86,641 [58,400 –
129,843]

116,775 ± 108,248
85,618 [58,308 –
138,117]

P-Value
<0.001
<0.001
1.000
<0.001

0.004
0.453

*Disposition stratified by routine (home), non-routine (Short-term hospital + SNF/Acute Rehab
+ Home with health care services), and other disposition categories, which include leaving
against medical advice, discharged to court/law enforcement, died in hospital, or location
unknown
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Table 6: Multivariate Logistic Regression for Non- Routine Discharge Disposition
Non- Routine Disposition*

OR

95% Confidence Interval
P-Value
(2.5%, 97.5%)
Black, Race
1.62
1.34, 1.96
<0.0001
Age
1.05
1.04, 1.05
<0.0001
Female, Sex
1.33
1.13, 1.58
0.0008
Medicaid
0.96
0.74, 1.24
0.8
Private Insurance
0.70
0.59, 0.83
<0.0001
Surgical Approach (Clipping)
4.65
4.02, 5.40
<0.0001
HTN
1.04
0.90, 1.20
0.6
A Fib
1.34
0.99, 1.80
0.06
COPD
1.50
1.19, 1.87
0.0004
Smoking
0.68
0.59, 0.79
<0.0001
PNC
9.00
6.69, 12.19
<0.0001
PSC
2.46
1.43, 4.12
0.0008
Bleeding
2.33
1.76, 3.09
<0.0001
DVT
6.21
2.90, 13.77
<0.0001
Respiratory Complications
5.10
3.69, 7.07
<0.0001
Cardiac Complication
3.39
1.89, 6.14
<0.0001
Only those standard covariates or variables with p-value below 0.1 from univariate analysis
included in multivariate logistic regression model
*Disposition dichotomized by routine (home) vs non-routine (Short-term hospital + SNF/Acute
Rehab + Home with health care services). Other disposition categories including leaving against
medical advice, discharged to court/law enforcement, died in hospital, or location unknown were
excluded from this analysis
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Figure 1: Flowchart for Querying Data
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Figure 2: Forrest Plot for Multivariate Logistic Regression Analysis on Routine vs. Non-Routine
Disposition
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CHAPTER 2
Reduced Impact of Gender on Discharge Disposition after Treatment Intervention for
Unruptured Intracranial Aneurysms
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INTRODUCTION
Gender differences in healthcare have the potential to affect patients significantly in cost,
quality of care and healthcare resource utilization38. As a result, policy initiatives have been
implemented to value care in order to reduce the possible gap of healthcare provision between
men and women39. Discharge disposition has increasingly become a surrogate marker,
representing quality of treatment between similar patient groups16,40.
Multiple studies encompassing a broad range of specialties have previously associated
disparities in gender with discharge disposition including emergency medicine, cardiovascular,
orthopedic, oncological, and gastrointestinal specialties41-45. In neurovascular surgery, discharge
disposition has been associated as an independent predictor of mortality, prognosis. and worse
clinical outcome46-48. Gender disparities in cerebrovascular patients have also been shown to
influence patient evaluation and likelihood of treatment49-51. In a longitudinal cohort study of
1,136 patients with hemorrhagic or ischemic strokes, Petrea et al. demonstrated that women were
significantly more disabled than men post-stroke in activities of daily living, and were 3.5-fold
more likely to be hospitalized at 3- to 6- months after compared to males52. Although female
gender has been linked to clinical outcomes in such cases, there remains a paucity of data on
whether gender influences patient discharge disposition after treatment intervention for
unruptured cerebral aneurysm.
The aim of this study was to investigate the influence gender has on post-procedural
discharge disposition after treatment for unruptured aneurysm.
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METHODS
Data Source and Patient Population
We utilized the Healthcare Cost and Utilization Project’s National Inpatient Sample
database (HCUP-NIS), a stratified discharge database representing 20% of all inpatient
admissions from nonfederal hospitals in the US. The HCUP-NIS is the largest all-payer
healthcare database in the US, containing approximately 7 to 8 million hospital admissions per
year. We performed a retrospective review using the years 2010 to 2014 of the NIS for all
patients undergoing treatment of a unruptured aneurysm.
The International Classification of Diseases, Ninth Revision, Clinical Modification [ICD9-CM] diagnosis and procedural coding system was used to identify patients and their respective
comorbidities and surgical interventions. All patients with a diagnosis of unruptured cerebral
aneurysm (ICD-9-CM 437.3) were identified. Patients with an additional diagnosis of
subarachnoid hemorrhage (ICD-9-CM 430) were excluded. ICD-9-CM procedural codes were
subsequently cross-matched to identify patients in the cohort that underwent endovascular
coiling (ICD-9-CM 39.52, 39.79, 39.72) or surgical clip placement (ICD-9-CM 39.51) for
definitive treatment of their aneurysm. Patients with missing information on gender, race,
mortality, insurance, hospital characteristics or cost data were excluded, as well. After, the cohort
was divided by Female and Male gender.

Data Collection
Patient demographic information, comorbidities and treating hospital characteristics were
collected for each patient. Demographic information included age (≥ 18 years), race, patient
income quartile and primary expected payer (Medicare, Medicaid, private insurer, self-pay, no
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charge, other). Patient income quartile was defined as the median household income for the
patient’s zip code in the specified year. Hospital characteristics included the region of the
hospital, size by bed volume (small, medium, large), and teaching status (rural, urban nonteaching, urban teaching). Comorbidities included HTN, hyperlipidemia (HLD), primary
hypercoagulable state, alcohol use, atrial fibrillation, chronic obstructive pulmonary disease
(COPD), congestive heart failure (CHF), coronary artery disease (CAD), diabetes, smoking,
autosomal dominant polycystic kidney disease (ADPKD), connective tissue disorder (CTD),
peripheral vascular disease (PVD), or past history of myocardial infarction (Past MI).
Complications for each admission were collected by indexing all additional diagnoses.
The ICD-9-CM diagnosis codes utilized were: postoperative neurologic complication,
postoperative surgical complication, sepsis, bleeding, accidental vessel puncture during the
procedure, deep vein thrombosis (DVT), urinary tract infection, respiratory complication,
abscess or vascular infection, urinary/renal complication, cardiac arrest or insufficiency,
perioperative stroke, myocardial infarction, postoperative infection, dysphagia and shock. The
primary outcome was discharge disposition between Female and Male gender. Discharge
disposition was examined by routine (home), non-routine (short-term hospital, skilled nursing
facility, home with healthcare services) and other (died in hospital, discharged to court/law, left
against medical advice, destination unknown) discharge. Patient length of hospital stay, inpatient
death, and total charge of admission were assessed as secondary outcomes.

Statistical Analysis
Categorical variables were described using counts and percentages. Continuous variables
were summarized using means and standard deviation if normally distributed and median with
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interquartile range (IQR) if a non-normal distribution was observed. An Anderson Darling test
for normality was conducted in order to determine the likelihood of a skewed distribution.
Comparison between the groups was conducted by c2 analysis for categorical variables and twosided independent t-test for parametric variables or Kruskal-Wallis testing for non-parametric
variables. A multivariate logistic regression analysis was used to determine the effect of each
risk factor on discharge disposition while adjusting for other potential risk factors. For the
purpose of this analysis, disposition was solely dichotomized by routine or non-routine
discharge. Other disposition categories including leaving against medical advice, discharged to
court/law enforcement, died in hospital or destination unknown were excluded from this portion
of the analysis. A p-value of less than 0.05 was determined to be statistically significant.
Statistical analysis was performed using R Studio, Version 1.1.383 (Rstudio Inc., Boston, MA).
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RESULTS
Patient Demographics, Comorbidities and Hospital Characteristics
There were 8,467 patients with unruptured aneurysms, of whom 2,076 (24.5%) were
Male and 6,391 (75.5%) were Female (Male: n=2,076 vs. Female: n=6,391) (Figure 1).
Between the two cohorts, age did not differ significantly (Male: 57 [50 – 66] years vs. Female:
57 [49 – 66] years), and the majority of both cohorts were White (Male: 73.7% vs. Female:
71.0%) (Table 1). The highest proportions of both cohorts were in the 26th-50th percentile
income quartile (Male: 26.7% vs. Female: 26.3%) (Table 1). The most common insurance status
between the cohorts was private insurance (Male: 45.2% vs. Female: 45.0%) (Table 1). The
largest proportion of patients undergoing treatment intervention occurred in the South (Male:
43.1% vs. Female: 41.6%), in large (Male: 82.0% vs. Female: 81.1%) urban teaching hospitals
(Male: 89.1% vs. Female: 90.0%) (Table 1).
Some baseline comorbidities varied significantly between the two cohorts, including
greater alcohol use (Male: 2.0% vs. Female: 0.8%, p<0.001), atrial fibrillation (Male: 5.7% vs.
Female: 3.7%, p<0.001), smoking (Male: 43.5% vs. Female: 39.9%, p=0.003) and past history
of MI (Male: 5.0% vs. Female: 2.8%, p<0.001) among the Male cohort and more diabetes
(Male: 2.3% vs. Female: 3.7%, p=0.003) among the Female cohort (Table 2). There were no
significant differences in hypercoagulable state (p=0.428), HTN (p=0.187), HLD (p=0.064),
COPD (p=0.832), CHF (p=0.077), coronary artery disease (p=0.117). ADPKD (p=0.706), CTD
(p=1.000), PVD (p=0.665), past MI (p<0.001) (Table 2).

Surgical Approach and Perioperative Complications
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The proportion of procedures offered between the Male and Female cohorts, was similar,
including endovascular coiling (Male: 56.2% vs. Female: 57.8%, p=0.195) and surgical clipping
(Male: 43.8% vs. Female: 42.2%, p=0.195) (Table 3). The proportion of perioperative stroke
was also similar (Male: 3.4% vs. Female: 3.5%, p=0.827) (Table 3). Overall, there was no
significant difference in postoperative complications between Male cohort and Female cohort
(Male: 14.1% vs. Female: 15.3%, p=0.193) (Table 4). Compared to Males, Female patients
were more likely to encounter bleeding complications (Male: 3.0% vs. Female: 4.6%, p=0.003)
and urinary tract infections (Male: 2.2% vs. Female: 4.5%, p<0.001) (Table 4). Females were
less likely to encounter respiratory complications (Male: 4.5% vs. Female: 2.7%, p<0.001) and
postoperative dysphagia (Male: 2.4% vs. Female: 1.4%, p=0.003) (Table 4).

Discharge Disposition, Mortality, Total Charge and Length of Hospital Stay
Between Male and Female cohorts, the latter had a significantly greater proportion of
patients experiencing discharge to a non-routine location (Male: 16.0% vs. Female: 18.4%,
p=0.010) (Table 5). There was a similar proportion of mortality between the two cohorts
(p=0.096) (Table 5). The median LOS for the Male cohort and Female cohort was 3 days (p =
0.019) (Table 5). Comparing total costs, the Male cohort on average incurred a $13,289 greater
charge for overall admission compared to the Female cohort (Male: $123,632 ± $114,274 vs.
Female: $110,343 ± $88,177, p<0.001) (Table 5). On multivariate logistic regression analysis,
while controlling for patient demographic variables, comorbidities and complications, Female
gender was not independently associated with routine discharge disposition [Odds-Ratio: 0.87,
95% CI (0.74, 1.01), p=0.07] (Table 6, Figure 2).
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DISCUSSION
In our nationwide analysis of 8,467 patients undergoing treatment intervention for
unruptured cerebral aneurysm, we demonstrated after multivariate analysis that female gender
was not an independent predictor of discharge disposition.
Previous studies have described a higher risk for females in the formation of aneurysms
and subsequent rupture. In a retrospective review of 87 patients with 111 unruptured aneurysms,
Juvela et al. demonstrated that female sex was a significant independent risk factor for de novo
aneurysm formation53. Furthermore, in a meta-analysis containing 4,705 patients with 6,556
unruptured aneurysms, Wermer et al. demonstrated that female gender was significantly
associated with a 1.6 relative-risk for rupture compared to males54. In a prospective study of
4,060 unruptured aneurysms, the International Study of Unruptured Intracranial Aneurysms also
showed that women comprised approximately 76% of their patient cohort55. In a retrospective
study of 55,720 patients with unruptured intracranial aneurysms and 69,887 patients with
subarachnoid hemorrhage using the NIS, Brinjikji et al. similarly demonstrated that the
proportion of women in their unruptured cohort was significantly greater compared to ruptured
cohort27. In a retrospective study of 682 treated intracranial aneurysms, Ghods et al.
demonstrated that the number of aneurysms was nearly 3-times greater in females than in
males56. Similar to the afore mentioned studies, we observed a near 3:1 female-to-male ratio in
our cohort of unruptured aneurysms treated by endovascular coiling or surgical clipping in the
U.S.
Gender disparities may also affect the management of patients harboring unruptured
aneurysms. Using the NIS database from 1998 to 2007, in a retrospective review of 14,765
patients with unruptured aneurysms, Lin et al. demonstrated that men were more likely than
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women to receive endovascular coiling10. Likewise, in another retrospective study, Brinjikji et al.
demonstrated that women had significantly higher odds of undergoing surgical clipping rather
than endovascular coiling on univariate analysis27. Similar to this study, in another retrospective
review of 7,236 elective admissions for patients receiving surgical clipping or endovascular
coiling in the U.S. subject to multivariate logistic regression analysis, Alshekhlee et al. found
after that females were 1.43-folds more likely than male patients to be treated with clipping than
coiling1. Conversely, other studies found no gender differences for managing unruptured
aneurysm. In a single-institution retrospective study of 252 patients undergoing either coiling or
clipping, Zanaty et al. found no difference in treatment choice between genders57. Similarly, in a
retrospective institutional study of 565 patients with cerebral aneurysms treated by coiling or
clipping, Hoh et al. showed no significant difference in gender treated by either intervention58.
Analogously, we found no significant difference in treatment approach between Male or Female
cohorts. This may represent a national trend towards greater standardization of aneurysm
treatment protocol in recent years.
While some studies have attempted to determine differences in treatment approach for
gender, other studies have assessed the impact of gender on clinical outcomes after treatment. In
a retrospective review of 105 patients with ruptured intracranial aneurysms, Chee et al. showed
male gender to be associated with favorable outcome both at discharge and 6 months postoperation59. Similarly, in a retrospective study of 492 consecutive patients with aneurysmal
subarachnoid hemorrhage, Cha et al. showed that male gender was a significant factor associated
with rebleeding after surgery60. In another retrospective review of 301 patients treated for
ruptured cerebral aneurysm, Park et al. demonstrated a significantly higher incidence of
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intraoperative aneurysm rupture in females, although by 3 months the rates of favorable outcome
were comparable between males (84.8%) and females (80.0%)61.
In contrast, several studies found no difference in clinical outcome between male and
female patients treated for cerebral aneurysm. In a retrospective review of 574 consecutive
patients with ruptured anterior communication artery aneurysms, Lin et al. demonstrated that
there was no statistically significant difference in clinical outcomes between genders at
discharge62. In another retrospective review of 468 consecutive patients with aneurysmal SAH
10 years after rupture, von Vogelsang et al. also showed that while the incidence of rupture was
higher in females, the rates of mortality and survival times were in fact equal between males and
females63. In a retrospective review of 617 patients with aneurysmal subarachnoid hemorrhage,
Hamdan et al. demonstrated that women were no more likely to experience poor clinical
outcome compared to males64. Similarly, in a retrospective review of 1,761 patients with
subarachnoid hemorrhage from aneurysm, Duijghuisen et al. found that in-hospital death and
clinical outcome at 3 months did not differ between men and women65. Analogous to the
aforementioned studies, our study demonstrated that female patients were just as likely as males
to encounter postoperative complications after endovascular coiling or microsurgical clipping.
Furthermore, female sex was not significantly associated with discharge disposition. Additional
studies are warranted to better understand patient- and institution-level factors that may influence
gender disparities in order to assess quality of care after treatment intervention for unruptured
aneurysm.
In an era of soaring healthcare expenditures, cost has become an important consideration
for hospitals when examining disparities between patient groups. In a retrospective study of 117
patients treated by endovascular coiling, Cheikh et al. demonstrated that on univariate linear
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regression, total cost of admission was not influenced by the gender of patients66. Similarly, in a
cost analysis of 125 unruptured intracranial aneurysms treated by coiling or clipping, Duan et al.
found that gender did not significantly alter total hospital costs for either endovascular coiling or
surgical clipping67. In another retrospective review of 55 patients with giant intracranial
aneurysms, Familiari et al. demonstrated that treatment cost was also not associated with patient
gender68. Conversely, some studies have found variations in cost benefit between males and
females. In a cost-effective, meta-analysis study by Greving et al., the authors found that the
benefit of treatment for intracranial aneurysms was greater in women compared to men of the
same age in terms of quality-adjusted life-years69. In another retrospective review using NIS data
years 2001-2008, Brinjikji et al. demonstrated on multivariate analysis that female sex was
associated with higher costs for coiling, but not for clipping70. Our study similarly showed a
significant difference in cost between men and women, however male patients tended to have
more expensive admissions overall. A prospective, randomized study would help more
accurately determine the impact gender has, if any, on treatment costs and resource utilization in
order to reduce the soaring costs associated with treatment for unruptured aneurysm.
Our study has several inherent limitations common to administrative databases, including
the NIS. First, its retrospective nature and its data available solely by ICD-9-CM coding, which
may have coding and reporting biases. Second, the NIS does not contain information on
important clinical details, including symptoms, patient preferences, or procedural details. The
NIS also does not have detailed information related to patient postoperative neurologic
outcomes, which could affect patient discharge status. Nevertheless, despite these limitations,
our study provides important information on the role gender may have in the treatment of
unruptured aneurysms.
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Table 1: Demographics and Hospital Characteristics
Variables
Age (Years)
Mean ± SD
Median [IQR]
Race (n, %)
White
Black
Hispanic
Asian or Pacific Islander
Native American
Other
Income Quartile (n, %)
0-25th
26th-50th
51st-75th
76th-100th
Healthcare Coverage (n, %)
Medicare
Medicaid
Private Insurance
Self-Pay
No Charge
Other
Hospital Demographics
Hospital Region (n, %)
Northeast
Midwest
South
West
Hospital Size (n, %)
Small
Medium
Large
Hospital Type (n, %)
Rural
Urban Non-Teaching
Urban Teaching

Male (n= 2,076)

Female (n=6,391)

P-Value

56.8 (12.3)
57 [50 - 66]

57.3 (12.1)
57 [49 - 66]

0.124
0.735
<0.001

1531 (73.7)
199 (9.6)
198 (9.5)
46 (2.2)
n<16
90 (4.3)

4538 (71.0)
863 (13.5)
603 (9.4)
115 (1.8)
42 (0.7)
230 (3.6)

528 (25.4)
554 (26.7)
501 (24.1)
493 (23.7)

1638 (25.6)
1680 (26.3)
1571 (24.6)
1502 (23.5)

0.962

<0.001
677 (32.6)
236 (11.4)
939 (45.2)
82 (3.9)
17 (0.8)
125 (6.0)

2282 (35.7)
755 (11.8)
2879 (45.0)
200 (3.1)
35 (0.5)
240 (3.8)
0.686

411 (19.8)
401 (19.3)
894 (43.1)
370 (17.8)

1315 (20.6)
1262 (19.7)
2658 (41.6)
1156 (18.1)
0.573

78 (3.8)
296 (14.3)
1702 (82.0)

269 (4.2)
938 (14.7)
5184 (81.1)
0.465

22 (1.1)
204 (9.8)
1850 (89.1)

57 (0.9)
581 (9.1)
5753 (90.0)
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Table 2: Comorbidities
Variables (n, %)
Alcohol Use
A Fib
Hypercoagulable State
HTN
HLD
COPD
CHF
Coronary Artery Disease
Diabetes
Smoking
ADPKD
CTD
Peripheral Vascular Disease
Past MI

Male (n= 2,076)
41 (2.0)
118 (5.7)
n<16
1204 (58.0)
162 (7.8)
170 (8.2)
52 (2.5)
n<16
47 (2.3)
904 (43.5)
n<16
n<16

Female (n=6,391)
48 (0.8)
237 (3.7)
29 (0.5)
3599 (56.3)
421 (6.6)
512 (8.0)
118 (1.8)
n<16
234 (3.7)
2548 (39.9)
n<16
n<16

P-Value
<0.001
<0.001
0.428
0.187
0.064
0.832
0.077
0.117
0.003
0.003
0.706
1.000

36 (1.7)
103 (5.0)

100 (1.6)
178 (2.8)

0.665
<0.001

ADPKD = Autosomal Dominant Polycystic Kidney Disease; CTD = Connective Tissue
Disorders
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Table 3: Surgical Approach
Procedure (n, %)
Endovascular Coiling
Microsurgical Clipping
Intraoperative Complications
Perioperative Stroke (n, %)

Male (n= 2,076)

Female (n=6,391)

P-Value

1166 (56.2)
910 (43.8)

3695 (57.8)
2696 (42.2)

0.195
0.195

70 (3.4)

224 (3.5)

0.827
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Table 4: Postoperative Complications
Complications (n, %)
Any Complication
PNC
PSC
Sepsis
Bleeding*
Accidental vessel puncture during
procedure or carotid injury
DVT
Urinary Tract Infection
Respiratory Complication
Abscess or Vascular Infection
Urinary/Renal Complication
Cardiac Arrest or Insufficiency
MI
Nerve Injury
Postoperative Infection
Dysphagia
Shock

Male (n= 2,076)
292 (14.1)
83 (4.0)
30 (1.4)
n<16
63 (3.0)
n<16

Female (n=6,391)
976 (15.3)
254 (4.0)
79 (1.2)
23 (0.4)
293 (4.6)
31 (0.5)

P-Value
0.193
1.000
0.534
0.251
0.003
0.734

n<16
46 (2.2)
93 (4.5)
n<16
n<16
19 (0.9)
n<16
0
n<16
50 (2.4)
n<16

35 (0.5)
285 (4.5)
175 (2.7)
n<16
n<16
58 (0.9)
n<16
0
n<16
90 (1.4)
n<16

1.000
<0.001
<0.001
1.000
0.025
1.000
0.018
0.025
0.003
0.584

PNC = Postoperative Neurologic Complications; PSC = Postoperative Surgical Complications
*Bleeding refers to both post-hemorrhagic anemia and hematoma formation
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Table 5: Mortality, Length of Stay and Discharge Disposition
Variables
Mortality (n, %)
Length of Stay (Days)
Mean ± SD
Median [IQR]
Disposition (n, %)*
Routine
Non-Routine
Other
Total Charge of Admission ($)
Mean ± SD
Median [IQR]

Male (n= 2,076)
n<16

Female (n=6,391)
21 (0.3)

P-Value
0.096

4.75 (6.78)
3 [1 - 5]

3.99 (4.88)
3 [1 - 5]

<0.001
0.019
0.010*

1727 (83.2)
333 (16.0)
16 (0.8)

5191 (81.2)
1173 (18.4)
27 (0.4)

123,632 ± 114,274
91,908 [61,082 –
147,107]

110,343 ± 88,177
88,466 [59,267 –
132,908]

<0.001
0.001

*Disposition stratified by routine (home), non-routine (Short-term hospital + SNF/Acute Rehab
+ Home with health care services), and other disposition categories, which include leaving
against medical advice, discharged to court/law enforcement, died in hospital, or location
unknown
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Table 6: Multivariate Logistic Regression for Routine Discharge Disposition
Routine Disposition*

OR

95% Confidence Interval
P-Value
(2.5%, 97.5%)
Female, Sex
0.87
0.74, 1.01
0.07
Black, Race
0.66
0.55, 0.80
<0.0001
Age
0.96
0.95, 0.96
<0.0001
Surgical Approach (Clipping)
0.23
0.20, 0.27
<0.0001
Medicaid
0.96
0.76, 1.20
0.7
Private Insurance
1.44
1.23, 1.68
<0.0001
A Fib
0.77
0.58, 1.02
0.07
CHF
0.69
0.47, 1.05
0.07
Diabetes
1.19
0.85, 1.70
0.3
Smoking
1.41
1.23, 1.61
<0.0001
Past MI
1.16
0.82, 1.68
0.4
Perioperative Stroke
0.13
0.09, 0.17
<0.0001
Bleeding
0.41
0.32, 0.53
<0.0001
UTI
0.21
0.16, 0.28
<0.0001
Respiratory Complications
0.21
0.16, 0.29
<0.0001
Dysphagia
0.17
0.11, 0.27
<0.0001
Only those standard covariates or variables with p-value below 0.1 from univariate analysis
included in multivariate logistic regression model
*Disposition dichotomized by routine (home) vs non-routine (Short-term hospital + SNF/Acute
Rehab + Home with health care services). Other disposition categories including leaving against
medical advice, discharged to court/law enforcement, died in hospital, or location unknown were
excluded from this analysis

44

Figure 1: Flowchart for Querying Data
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Figure 2: Forrest Plot for Multivariate Logistic Regression Analysis on Routine vs. Non-Routine
Disposition
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CHAPTER 3
Patient Risk Factors for Extended Length of Stay following Surgical Clipping and
Endovascular Coiling of Unruptured Adult Cerebral Aneurysms
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INTRODUCTION
In the past decade, there has been increasing emphasis on reducing healthcare costs and
identifying quality metrics to improve the overall value of care. Across many surgical specialties,
length of hospital stay (LOS) has become a proxy for the financial impact of a procedure on
hospitals71. While many hospitals have tried to standardize treatment interventions for specific
conditions, variability in treatment practices persists and importantly impacts overall value of
care.72
Recently, there has been a rapid technical evolution in the treatments of unruptured
aneurysms, including clipping (e.g., mini-craniotomy, intraoperative indocyanine green
angiography) and coiling (e.g., complex-shaped (3D) coils, stent-assisted coiling, flow
diversion)73-77, with the latter gaining in popularity in recent years. Notwithstanding, there
remains tremendous variability between practitioners in terms of treatment philosophy and a
paucity of high-quality data to guide their choice. While several studies have focused on overall
efficacy and complication rates, relatively few assessed the impact of clinical factors on
prolonged LOS following the treatment of unruptured aneurysms3,55,78-82. Understanding the
clinical factors contributing to extended inpatient LOS, including those related to baseline
illness, postoperative complications, or variations in hospital/physician practice, may improve
the quality of care by identifying those patients most at risk for extended LOS.
Therefore, the aim of this study was to identify the patient- and hospital-level factors
associated with extended LOS following intervention for adult, unruptured cerebral aneurysms.
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METHODS
Data Source and Patient Population
The Healthcare Cost and Utilization Project’s National Inpatient Sample (NIS) database
is a stratified discharge database representing 20% of all inpatient admissions from nonfederal
hospitals in the US. It is the largest all-payer healthcare database in the US, containing
approximately 7 to 8 million hospital admissions per year. A retrospective study was performed
using years 2010 to 2014 of the NIS for all inpatient admissions undergoing either surgical
clipping or endovascular coiling of an unruptured aneurysm.
The International Classification of Diseases, Ninth Revision, Clinical Modification [ICD9-CM] diagnosis and procedural coding system was used to identify patients and their respective
comorbidities and surgical interventions. All patients with an unruptured cerebral aneurysm
(ICD-9-CM 437.3) were identified. Patients with an additional diagnosis of subarachnoid
hemorrhage (ICD-9-CM 430) were excluded. ICD-9-CM procedural codes were subsequently
cross-matched to identify patients in the cohort that underwent either endovascular coiling (ICD9-CM 39.52, 39.79, 39.72) or surgical clipping (ICD-9-CM 39.51) for treatment of cerebral
aneurysm. For the purpose of the analysis, “coiling” refers to “embolization” and includes
balloon-assisted coiling, stent-assisted coiling, and use of flow-diverting stents, e.g., Pipeline
Embolization Device (Medtronic Neurovascular, Irvine, California). Patients for which both
clipping and coiling were performed, had missing LOS and/or cost data, were all excluded.
Patients were then dichotomized according to whether they encountered an extended
postoperative hospital LOS, which was defined as LOS greater than the 75th percentile for the
entire cohort (>5 days).
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Data Collection
Patient demographic information, comorbidities and treating hospital characteristics were
collected. Demographic information included age (≥ 18 years), gender, race, patient income
quartile and primary expected payer. Hospital characteristics included the region of the hospital,
size by bed volume, and teaching status. The Elixhauser Comorbidity Index was used to evaluate
incidence of alcohol use, atrial fibrillation, deficiency anemias, rheumatoid arthritis/collagen
vascular diseases, chronic blood loss anemia, congestive heart failure (CHF), chronic pulmonary
disease, coagulopathy, depression, diabetes, hypertension (HTN), hypothyroidism, liver disease,
obesity, peripheral vascular disease (PVD), and renal failure. Hyperlipidemia (HLD) (ICD-9-CM
272.0) and smoking (ICD-9-CM 305.1, 649.0, 989.84, V15.82) were also assessed.
Complications for each admission were collected by indexing additional diagnoses.
Complications assessed for included perioperative stroke, postoperative neurologic complication,
postoperative surgical complication, sepsis, bleeding, accidental vessel puncture during the
procedure, deep vein thrombosis (DVT), urinary tract infection, respiratory complication,
abscess or vascular infection, cardiac arrest or insufficiency, nerve injury, postoperative
infection, dysphagia and shock. We then additionally assessed patient outcomes of discharge
disposition and total cost of hospital admission. All-payer inpatient cost-to-charge ratios (CCR)
were used to convert total hospital charge to total cost of hospital care.

Statistical Analysis
Discharge weights accounting for the redesign of the NIS in 2012 were used to calculate
national estimates. Parametric data were expressed as mean ± SD and compared via two-sided
independent t test. Nonparametric data were expressed as median (interquartile range) and
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compared via the Mann-Whitney U test. Nominal data were compared with the c2 test. For our
primary hypothesis, we fit univariate and multivariate logistic regression with extended LOS as
the dependent variable. Backward stepwise multivariate logistic regression analysis was used to
select variables in a final model, using 0.1 as entry and stay criteria. We forced age and female
sex into the model to prevent confounding given the joint associations between these covariates
and primary aneurysm development. A P-value of less than 0.05 was determined to be
statistically significant. Statistical analysis was performed using R Studio, Version 1.1.383
(RStudio Inc., Boston, MA).
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RESULTS
Patient Demographics, Comorbidities, and Hospital Characteristics
From the NIS database, 46,880 adult patients who underwent either microsurgical
clipping or endovascular coiling of an unruptured cerebral aneurysm from 2010 – 2014 were
identified. There were 37,106 patients who had a LOS £5 days and 9,774 patients with an
Extended LOS (LOS >5 Days) (Table 1). The Extended LOS cohort was older, with the mean
age being 58.3 ± 12.6 years, compared to 56.8 ± 12.0 years for the Normal LOS cohort
(P<0.001) (Table 1). A greater percentage of the Normal LOS cohort were Female (Normal
LOS: 76.6% vs. Extended LOS: 71.7%, P<0.001) and White (Normal LOS: 73.2% vs. Extended
LOS: 64.9%, P<0.001) compared to the Extended LOS cohort (Table 1). Patient income
quartiles were evenly distributed for both cohorts (Table 1). The largest proportion of patients
with Normal LOS had Private Insurance (47.4%), whereas the largest proportion of patients with
extended LOS had Medicare (38.5%) (Table 1). For both cohorts, the largest proportion of
aneurysm treatment was performed in the South (Normal LOS: 39.2%; Extended LOS: 38.2%) in
large hospitals (Normal LOS: 81.4%; Extended LOS: 81.0%), that were teaching hospitals in an
urban setting (Normal LOS: 90.6%; Extended LOS: 89.7%) (Table 1).
Comorbidities and diseases were overall greater in the extended LOS cohort (Table 2).
Compared to the Normal LOS cohort, the extended LOS cohort had a significantly greater
proportion of alcohol use (2.2% vs. 4.7%, P<0.001), atrial fibrillation (3.3% vs. 6.9%, P<0.001),
deficiency anemias (6.8% vs. 15.9%, P<0.001), chronic blood loss anemia (0.3% vs. 1.2%,
P<0.001), congestive heart failure (1.8% vs. 4.0%, P<0.001), chronic pulmonary disease (18.0%
vs. 22.2%, P<0.001), coagulopathy (1.3% vs. 5.6%, P<0.001), diabetes (10.8% vs. 17.1%,
P<0.001), hypertension (59.5% vs. 69.4%, P<0.001), liver disease (1.3% vs. 2.5%, P<0.001),
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obesity (8.8% vs. 12.5%, P<0.001), peripheral vascular disease (4.3% vs. 7.2%, P<0.001), renal
failure (2.4% vs. 6.2%, P<0.001), and valvular disease (2.6% vs. 3.4%, P=0.04) (Table 2).
Smoking was more common in the Normal LOS cohort (42.1% vs. 36.3%, P<0.001), and there
was no significant difference between rheumatoid arthritis/collagen vascular diseases (P=0.27),
depression (P=0.22), hyperlipidemia (P=0.84), and hypothyroidism (P=0.60) between the two
cohorts (Table 2).

Intervention Type and Postoperative Complications
A greater proportion of the normal LOS cohort underwent coiling (Normal LOS: 63.0%
vs. Extended LOS: 33.5%, P<0.001), while more patients in the extended LOS cohort were
treated by clipping (Normal LOS: 37.0% vs. Extended LOS: 66.5%, P<0.001) (Table 3). There
was a significantly greater proportion of patients in the extended LOS cohort with post-operative
complications than the Normal LOS cohort (Normal LOS: 7.3% vs. Extended LOS: 43.8%,
P<0.001) (Table 3). Compared to Normal LOS, the extended LOS patients had a greater
proportion of perioperative stroke (1.0% vs. 12.7%, P<0.001), postoperative neurologic
complication (1.3% vs. 14.3%, P<0.001), postoperative surgical complication (0.8% vs. 3.1%,
P<0.001), sepsis (0.0% vs. 2.0%, P<0.001), bleeding (2.7% vs. 10.8%, P<0.001), accidental
vessel puncture or carotid injury (0.4% vs. 1.1%, P<0.001), DVT (0.1% vs. 2.2%, P<0.001),
urinary tract infection (1.2% vs. 13.3%, P<0.001), respiratory complication (0.9% vs. 11.8%,
P<0.001), abscess or vascular infection (0.0 vs. 0.4%, P<0.001), postoperative infection (0.0%
vs. 0.4%, P<0.001), dysphagia (0.5% vs. 6.1%, P<0.001), and shock (0.1% vs. 0.3%, P=0.04)
(Table 3).
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Among the patients with Normal LOS, 92.7% had no postoperative complications, 5.5%
had 1 complication, and 1.8% had >1 complication (Table 3). Among the patients with extended
LOS, 56.2% had no post-operative complications, 20.4% had 1 complication, and 23.4% had >1
complication (P<0.001) (Table 3).

Total Cost, Discharge Disposition and Predictors of Extended LOS
On average, patient admissions encountering extended LOS incurred $26,145 more in
total cost than patients with normal LOS (Normal LOS: $26,050 ± 13,430 vs. Extended LOS:
$52,195 ± 37,252, P<0.001) (Table 4). Compared to the Normal LOS cohort, the extended LOS
cohort had more patients experience non-routine discharge (Normal LOS: 8.5% vs. Extended
LOS: 52.5%, P<0.001) (Table 4). Stepwise multivariate regression analysis identified Female
sex, Black and Hispanic Race compared to White Race, Private and Other Insurance compared to
Medicare, alcohol use, atrial fibrillation, deficiency anemias, chronic blood loss anemia,
congestive heart failure, coagulopathy, diabetes, liver disease, obesity, peripheral vascular
disease, renal failure, smoking, clipping intervention, and complications as independent extended
LOS risk factors (Table 5). Compared with no complications, the odds ratio for extended LOS
was 5.14 (95% confidence interval (C.I.), 4.30 – 6.14) for patients with 1 complication and 19.58
(95% C.I., 15.75 – 24.34) for patients with >1 complication (Table 5).
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DISCUSSION
In our nationwide study of 46,880 adult patients with unruptured cerebral aneurysms, we
demonstrated that multiple patient-level factors were significantly associated with extended LOS
following treatment intervention. Specifically, we found that patients with extended LOS had a
greater likelihood of presenting with baseline illness and comorbidities, undergoing surgical
clipping, encountering inpatient post-operative complications, had poorer discharge disposition
and incurred overall higher costs of admission compared to patients with normal LOS.
In an era of unprecedented importance on identifying at-risk patients preoperatively, it is
necessary to identify the impact clinical factors have on prolonged LOS following treatment of
unruptured aneurysms. Multiple studies have attempted to identify treatment choice as a
predictor of extended LOS for unruptured aneurysms. In a retrospective study of 140 unruptured
aneurysms, Sharma et al. demonstrated that clipping was associated with a greater than 2-fold
increase in LOS83. Similarly, in a retrospective analysis of 9,399 unruptured aneurysms coiled or
clipped in the NIS database, Hoh et al. demonstrated that clipping as compared to coiling was
associated with an average of 1.8 times more days in hospitalization7. Likewise, in a
retrospective study of the NIS, Barker et al. demonstrated that length of stay was shorter for
coiling compared to clipping (2 days versus 5 days, respectively)84. Finally, in a recent metaanalysis of 24,856 unruptured aneurysms treated by clipping and 31,309 unruptured aneurysms
treated by coiling, Zhang et al. found that the majority of studies assessed concluded LOS of
coiling was significantly shorter than clipping. In accordance, our study demonstrated that
clipping was independently associated with extended length of hospital stay after treatment of
unruptured aneurysms.
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While clipped patients may experience longer inpatient LOS, choice of procedure may
not be the only determinant of extended LOS. Fewer studies, however, have attempted to
investigate the impact baseline illnesses have on LOS following aneurysm treatment. In the study
by Hoh et al., the authors found that not White race, older age, anemia, CHF, coagulopathy,
diabetes, drug abuse, absence of hypertension, electrolyte disorders, neurological disorders, PVD
and renal failure were associated with length of hospitalization7. In another study investigating
367 unruptured aneurysms treated by surgical clipping or endovascular coiling at the University
of Florida, Hoh et al. found that surgical treatment, male sex, Medicaid or self-pay payor, and
larger aneurysm size were all associated with longer hospitalization after multivariate analysis58.
Our results complement these studies, finding that Black and Hispanic race, alcohol use, anemia,
CHF, coagulopathy, diabetes, PVD, and renal failure all increase the likelihood of extended
LOS. In addition, female sex and private insurance in our study similarly predicted reduced
likelihood of encountering extended LOS.
As variability in hospital patterns and treatment philosophy continues to rise, some
studies have focused on hospital-level factors predicting LOS. In a study of the NIS database of
31,070 unruptured aneurysms that were coiled or clipped electively, Salahuddin et al. found that
treated patients encountered shorter LOS as hospital size increased85. Contrarily, Hoh et al. found
no association of hospital volume with LOS7. Likewise, in a retrospective cohort study of 2,069
patients with unruptured aneurysms treated in the state of California, Johnston et al. showed that
hospital volume was not a significant predictor of LOS (P>0.20)86. Similar to the
aforementioned studies, we found no difference in hospital size or teaching status for patients
encountering extended LOS compared to normal LOS. Identifying differences between various
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hospital types may optimize the treatment and care of patients at higher risk for prolonged
hospitalization.
Post-hospital discharge complication and readmission rates have become increasingly
scrutinized as hospitals with higher readmission rates may be subject to penalties by the Centers
for Medicare and Medicaid Services. Studies have found that certain aspects of aneurysm
clipping and coiling may lead to increased resource utilization after discharge. Using the
Thomson Reuters’ MarketScan Database, Lad et al. demonstrated in a propensity score-matched
cohort of 4,504 patients with unruptured aneurysms, that while the likelihood of 30- and 90-day
complications was significantly higher in those having undergone surgical clipping, the amount
of postoperative angiograms and outpatient services used at 1, 2 and 5 years was significantly
greater in those having been treated with coiling87. In another retrospective study using the
American College of Surgeons’ National Surgical Quality Improvement Program (NSQIP),
Kerezoudis et al. showed from a population of 662 patients who underwent surgical clipping for
unruptured aneurysms, 16.3% experienced at least one major complication within 30 days of the
procedure88. Further studies are necessary to identify the impact that treatment of unruptured
aneurysms have on short- and long-term unplanned hospital readmission rates.
While hospitals continue to transition from unbundled, fee-for-service payment models to
value-based care, cost has become an increasingly important consideration. In the study at
University of Florida, Hoh et al. demonstrated that length of hospitalization and treatment was
significantly associated with hospital costs58. In the. retrospective study of 2,535 patients treated
for unruptured aneurysm, Higashida et al. found that endovascular coiling was associated with
shorter LOS and lower total hospital costs compared to surgical clipping89. Likewise, Bekelis et
al. also demonstrated a higher cost expenditure for patients treated with clipping in the 1-year
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period following the index procedure90. Contrary to these findings, some studies have found that
even while accounting for LOS, costs are similar between treatment modalities. In a metaanalysis study, Zhang et al. showed that although LOS was shorter for coiling, total hospital
costs were similar between clipping and coiling cohorts at 1-year9. Therefore, identifying
treatment approaches that are associated with lower complication rates, shorter LOS, routine
discharges, and decreased unplanned readmission rates will improve the overall value of care.
Our study has several inherent limitations common to administrative databases, including
the NIS. First, the data are retrospective and only available by ICD-9-CM coding with wellknown coding and reporting biases. Second, the NIS does not contain information on aneurysm
size, shape, location, or complexity, all of which may impact clinical decision-making and postoperative outcomes. Third, the NIS does not have detailed information related to postoperative
neurologic outcomes. Finally, as the NIS has information specific to only one inpatient
admission, we are unable to comment on differences in long-term functional outcomes nor
subsequent readmission events. Nevertheless, we provide important findings on the current state
of surgical and endovascular management of unruptured cerebral aneurysms and the associated
morbidity, complications, short-term outcomes, and hospital LOS associated with these two
procedures.
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Table 1: Patient Demographics and Hospital Characteristics
Variables
Age (Years)
Mean ± SD
Median [IQR]
Female (%)
Race (%)
White
Black
Hispanic
Other
Income Quartile (%)
0-25th
26-50th
51-75th
76-100th
Healthcare Coverage (%)
Medicare
Medicaid
Private Insurance
Other
Hospital Region (%)
Northeast
Midwest
South
West
Hospital Size (%)
Small
Medium
Large
Hospital Type (%)
Rural
Urban Non-Teaching
Urban Teaching

Normal LOS (£ 5
Days) (n= 37,106)

Extended LOS (> 5
Days) (n= 9,774)

P-Value

56.8 ± 12.0
57 [49 – 66]
76.6

58.3 ± 12.6
59 [51 – 67]
71.7

<0.001
<0.001
<0.001
<0.001

73.2
11.4
9.2
6.2

64.9
16.7
11.2
7.2

24.4
26.1
24.4
24.1

27.1
26.9
25.0
20.1

0.01

<0.001
33.5
11.2
47.4
8.0
Hospital Demographics

38.5
14.8
36.8
9.9
0.07

19.1
23.5
39.2
18.2

18.6
20.9
38.2
22.2

4.4
14.2
81.4

6.2
12.8
81.0

0.16

0.68
0.7
8.7
90.6

0.8
9.5
89.7
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Table 2: Admission and Patient Comorbidities
Variables (%)
Alcohol Use
Atrial Fibrillation
Deficiency anemias
Rheumatoid
arthritis/collagen vascular
diseases
Chronic blood loss anemia
Congestive heart failure
Chronic pulmonary disease
Coagulopathy
Depression
Diabetes
Hypertension
Hyperlipidemia
Hypothyroidism
Liver disease
Obesity
Peripheral vascular disease
Renal failure
Smoking
Valvular disease

Normal LOS (£ 5 Days)
(n= 37,106)
2.2
3.3
6.8
2.8

Extended LOS (> 5
Days) (n= 9,774)
4.7
6.9
15.9
3.3

P- Value

0.3
1.8
18.0
1.3
15.1
10.8
59.5
6.7
11.9
1.3
8.8
4.3
2.4
42.1
2.6

1.2
4.0
22.2
5.6
16.2
17.1
69.4
6.6
12.3
2.5
12.5
7.2
6.2
36.3
3.4

<0.001
<0.001
<0.001
<0.001
0.22
<0.001
<0.001
0.84
0.60
<0.001
<0.001
<0.001
<0.001
<0.001
0.04

<0.001
<0.001
<0.001
0.27
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Table 3: Intervention and Postoperative Complications
Variables (%)
Intervention
Endovascular coiling
Microsurgical clipping
Complications
Perioperative stroke
Postoperative neurologic
complication
Postoperative surgical
complication
Sepsis
Bleeding
Accidental vessel puncture or
carotid injury
Deep vein thrombosis
Urinary tract infection
Respiratory complication
Abscess or vascular infection
Cardiac arrest or insufficiency
Nerve injury
Postoperative infection
Dysphagia
Shock
Any Complication
Number of Complications
0
1
>1

Normal LOS (£ 5 Days)
(n= 37,106)

Extended LOS (> 5
Days) (n= 9,774)

63.0
37.0

33.5
66.5

1.0
1.3

12.7
14.3

<0.001
<0.001

0.8

3.1

<0.001

0.0
2.7
0.4

2.0
10.8
1.1

<0.001
<0.001
<0.001

0.1
1.2
0.9
0.0
0.4
0.0
0.0
0.5
0.1
7.3

2.2
13.3
11.8
0.4
2.8
0
0.4
6.1
0.3
43.8

<0.001
<0.001
<0.001
<0.001
<0.001

92.7
5.5
1.8

56.2
20.4
23.4

P- Value
<0.001

<0.001
<0.001
0.04
<0.001
<0.001

61

Table 4: Postoperative Inpatient Outcomes
Variables
Total Cost of Admission ($)
Mean ± SD
Median [IQR]
Disposition (%)*
Routine
Non-Routine
Other

Normal LOS (£ 5 Days)
(n= 37,106)

Extended LOS (> 5 Days)
(n= 9,774)

P-Value

26,050 ± 13,430
23,351 [17,507– 31,353]

52,195 ± 37,252
42,505 [29,812– 60,792]

<0.001
<0.001
<0.001

91.2
8.5
0.2

45.8
52.5
1.6

*Disposition stratified by routine (home), non-routine (Short-term hospital + SNF/Acute Rehab
+ Home with health care services), and other (leaving against medical advice, discharged to
court/law enforcement, died in hospital, or location unknown)

62

Table 5: Logistic Multivariate Regression Analysis on Extended Length of Stay
Age
Female sex
Race
White
Black
Hispanic
Other
Insurance status
Medicare
Medicaid
Private insurance
Other
Comorbidity
Alcohol Use
Atrial Fibrillation
Deficiency anemias
Chronic blood loss anemia
Congestive heart failure
Chronic pulmonary disease
Coagulopathy
Diabetes
Hypertension
Liver disease
Obesity
Peripheral vascular disease
Renal failure
Smoking
Valvular disease
Intervention
Coiling
Clipping
Complications
No
1 Complication
>1 Complication

Univariate Model
1.01 (1.01, 1.02)
0.78 (0.69, 0.87)

Multivariate Model
1.01 (0.99, 1.01)
0.73 (0.63, 0.84)

P - Value
0.13
<0.001

REFERENCE
1.64 (1.41, 1.92)
1.49 (1.21, 1.82)
1.37 (1.14, 1.64)
1.30 (1.07, 1.58)
1.31 (1.06, 1.63)
1.27 (0.98, 1.63)

<0.001
<0.01
0.07

REFERENCE
1.15 (0.97, 1.36)
1.24 (0.99, 1.55)
0.68 (0.60, 0.76)
0.76 (0.63, 0.91)
1.09 (0.90, 1.31)
1.40 (1.09, 1.79)

0.06
<0.01
<0.01

2.18 (1.70, 2.80)
2.15 (1.73, 2.67)
2.60 (2.20, 3.08)
4.38 (2.58, 7.46)
2.33 (1.75, 3.10)
1.30 (1.15, 1.46)
4.64 (3.42, 6.31)
1.71 (1.49, 1.97)
1.54 (1.38, 1.72)
1.96 (1.37, 2.80)
1.47 (1.26, 1.73)
1.72 (1.39, 2.13)
2.66 (2.10, 3.36)
0.78 (0.70, 0.88)
1.32 (1.02, 1.72)

1.89 (1.37, 2.62)
1.71 (1.29, 2.25)
2.24 (1.84, 2.73)
3.91 (2.06, 7.43)
1.84 (1.29, 2.25)
Removed
2.70 (1.85, 3.92)
1.21 (1.02, 1.43)
1.14 (1.00, 1.30)
1.74 (1.11, 2.72)
1.27 (1.05, 1.54)
1.42 (1.09, 1.84)
1.47 (1.07, 2.01)
0.74 (0.65, 0.84)
Removed

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.03
0.05
0.02
0.02
<0.01
0.02
<0.001

REFERENCE
3.38 (2.95, 3.87)
3.86 (3.34, 4.47)

<0.001

REFERENCE
6.07 (5.23, 7.04)
5.14 (4.30, 6.14)
21.5 (17.74, 25.96)
19.58 (15.75, 24.34)

<0.001
<0.001

Results displayed as odds ratio (95% confidence interval)
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CONCLUSION TO CHAPTERS
While previous studies have attempted to explore differences in patients undergoing
clipping vs. coiling of unruptured aneurysms, only a handful have assessed the impact of race,
gender, and/or modifiable risk factors on discharge disposition and length of hospitalization. Due
to the paucity of such studies pertaining to the treatment of unruptured aneurysms, this thesis
aimed to use the NIS database to identify race and gender-related differences in the care for
unruptured aneurysms treated by endovascular coiling or surgical clipping. Furthermore, the NIS
was used to assess nationwide patient risk factors for extended hospitalization.
We establish that racial disparities significantly impacted healthcare resource utilization
in patients undergoing treatment intervention for unruptured aneurysms (Chapter 1) and
demonstrate that gender disparities may have a reduced impact on healthcare resource utilization
in patients undergoing treatment intervention for unruptured aneurysms (Chapter 2). We further
determine that extended length of stay after treatment of unruptured aneurysm is influenced by a
number of modifiable patient-specific factors, including both pre- and peri-operative variables
(Chapter 3). These independent predictors may help identify patients at risk for prolonged length
of hospital stay after treatment of unruptured aneurysms.
Together, our studies draw attention to patients at increased risk for worse clinical
outcomes after intervention for unruptured aneurysms. In a cost-consciousness healthcare
environment, stratifying aspects of racial and gender disparities may allow for improvement in
patient care and reduced healthcare costs. Finally, despite the limitations associated with large
administrative databases, our studies provide important findings on the current state of surgical
and endovascular management of unruptured cerebral aneurysms and morbidity, complications,
short-term outcomes, and hospital LOS associated with intervention.
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